Literature DB >> 16507364

Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis.

Yves Nominé1, Murielle Masson, Sebastian Charbonnier, Katia Zanier, Tutik Ristriani, François Deryckère, Annie-Paule Sibler, Dominique Desplancq, Robert Andrew Atkinson, Etienne Weiss, Georges Orfanoudakis, Bruno Kieffer, Gilles Travé.   

Abstract

Oncoprotein E6 is essential for oncogenesis induced by human papillomaviruses (HPVs). The solution structure of HPV16-E6 C-terminal domain reveals a zinc binding fold. A model of full-length E6 is proposed and analyzed in the context of HPV evolution. E6 appears as a chameleon protein combining a conserved structural scaffold with highly variable surfaces participating in generic or specialized HPV functions. We investigated surface residues involved in two specialized activities of high-risk genital HPV E6: p53 tumor suppressor degradation and nucleic acid binding. Screening of E6 surface mutants identified an in vivo p53 degradation-defective mutant that fails to recruit p53 to ubiquitin ligase E6AP and restores high p53 levels in cervical carcinoma cells by competing with endogeneous E6. We also mapped the nucleic acid binding surface of E6, the positive potential of which correlates with genital oncogenicity. E6 structure-function analysis provides new clues for understanding and counteracting the complex pathways of HPV-mediated pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507364     DOI: 10.1016/j.molcel.2006.01.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  88 in total

1.  Genetic variations in human papillomavirus and cervical cancer outcomes.

Authors:  Janet S Rader; Shirng-Wern Tsaih; Daniel Fullin; Miriam W Murray; Marissa Iden; Michael T Zimmermann; Michael J Flister
Journal:  Int J Cancer       Date:  2019-01-04       Impact factor: 7.396

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

Review 3.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

4.  A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein.

Authors:  Susanne Dymalla; Martin Scheffner; Elvira Weber; Peter Sehr; Claudia Lohrey; Felix Hoppe-Seyler; Karin Hoppe-Seyler
Journal:  J Mol Med (Berl)       Date:  2008-12-21       Impact factor: 4.599

5.  The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain.

Authors:  Sandy S Tungteakkhun; Maria Filippova; Jonathan W Neidigh; Nadja Fodor; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

6.  New variants of human papillomavirus type 18 identified in central Brazil.

Authors:  Daniela Marreco Cerqueira; Tainá Raiol; Nazle Mendonça Collaço Véras; Natália von Gal Milanezi; Fádia Aguiar Amaral; Marcelo de Macedo Brígido; Cláudia Renata Fernandes Martins
Journal:  Virus Genes       Date:  2008-07-29       Impact factor: 2.332

Review 7.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

8.  Induction of SiHa cells apoptosis by nanometer realgar suspension and its mechanism.

Authors:  Rong Liu; Demin Pu; Yan Liu; Yanxiang Cheng; Ling Yin; Tian Li; Libo Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

9.  Design and characterization of an enhanced repressor of human papillomavirus E2 protein.

Authors:  Kakoli Bose; Gretchen Meinke; Andrew Bohm; James D Baleja
Journal:  FASEB J       Date:  2011-04-11       Impact factor: 5.191

10.  The full-length isoform of human papillomavirus 16 E6 and its splice variant E6* bind to different sites on the procaspase 8 death effector domain.

Authors:  Sandy S Tungteakkhun; Maria Filippova; Nadja Fodor; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.